NCI Failed to Publish Two Bypass Budgets As Funds Tightened and Sequestration Set In
Guest Editorial: Andrew Vickers on PSA Skepticism, Rational and Irrational
UT Board Announces Support for MD Anderson Tenure System
Study: Drug Discounts Used For Wealthier Patients In Many 340B-Enrolled Hospitals
In Brief: ESMO Names Annual Award Winners
Drugs and Targets: Akynzeo approved for chemotherapy-related nausea
Trending Stories
- The story of daraxonrasib is the ultimate hero’s journey
A narrative curve with twists, turns, intrigue, drama—and a blow to a mighty foe - At Senate hearing, Brown’s El-Deiry and other witnesses say they were targeted for arguing that mRNA vaccine may be linked to cancer
- Pancreatic cancer breakthrough came from smart scientists making smart bets—not from politicization of science
- Pancreatic cancer finally starts to budge as daraxonrasib doubles overall survival
- As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab
The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded - Political appointees to be inserted into all stages of making research funding awards if OMB rule becomes final










